// App-Quantinova.ai

: Lung deposition of two bronchodilators in subjects with (COPD when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI

Researchers

Presenter

  • Glenn Crater

Principal Investigators

  • Edmund Moran

  • Jonathan Ward

  • Dennis Belmans

  • Cedric Van Holsbeke

Medical Centers

  • Theravance Biopharma US, Inc., South San Francisco, United States of America

  • Mylan Pharma UK Ltd., Sandwich, United Kingdom,

  • FLUIDDA, Antwerp, Belgium

Locations

  • United States

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Revefenacin

  • Tiotropium bromide

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A